Mindful Walking Program for Older African Americans
Status
Conditions
Treatments
Details and patient eligibility
About
The goal of this clinical trial is to understand the beneficial role of mindful walking in sustaining cognitive health in African American older adults who have elevated risk of developing neuropsychological diseases. The main question it aims to answer is "Does a multi-session mindful walking intervention lead to promising signals of sustaining cognitive health in vulnerable AA older adults?" The researchers in this 2-arm randomized controlled trial will compare the mindful walking group with a delayed mindful walking to see if the intervention efficacy is observed at multiple follow-up period.
Full description
African American (AA) older adults in the U.S. are disproportionally impacted by ADRD compared to other races and ethnicities. Mindful walking integrates two potentially protective factors of ADRD by elevating mindfulness and physical activity (i.e., walking), resulting in a synergistic behavioral strategy that is feasible and safe for older adults. However, the efficacy of using this intervention for cognitive health outcomes has not been tested using experimental designs. This study is a community-based, mindful walking randomized controlled trial to examine its efficacy on cognitive and other health outcomes in ADRD at-risk, AA older adults. This study will recruit 114 older adults (ages 60+ years) with elevated risk of developing ADRD from the Midlands region of South Carolina. Older adults were randomly assigned to participate in 24 sessions of mindful walking or a delayed mindful walking group (n=57 in each group). The study outcomes include various key brain health determinants, including cognitive function, quality of life, psychological well-being, physical activity, mindfulness, sleep, and overall health status. Participants in both groups follow identical measurement protocol of at baseline, 12 weeks, 18 weeks, and 24 weeks. The outcome measures are administered in the lab and in everyday settings. This study will generate preliminary evidence regarding the effects of mindful walking on sustaining cognition health. It will also inform future large-scale effectiveness trials to validate our study findings. If successful, this mindful walking program can be scaled up as a low-cost and viable lifestyle strategy to promote healthy cognitive aging in diverse older adult populations, including those at greatest risk.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- African American ages 60 and above
- Mild symptoms of cognitive decline or MCI
- Physically inactive or insufficiently active (based on the 2018 US guidelines)
- Adequate hearing and visual ability to complete study tasks and assessments
- English proficiency
- Medically stable with or without medication
- Capable of providing informed consent
- Willing to be randomized to one of the two groups
Exclusion criteria
- Clinical diagnosis of ADRD or other brain abnormalities (e.g., strokes, epilepsy, Parkinson's disease
- Clinical diagnosis of psychiatric disorders (i.e., depression, post-traumatic stress disorder, bipolar disorder)
- Unable to walk independently (i.e., need caregiver's assistance) 4) Plan to have surgery or relocate outside the area within the next 6 months
- Currently participate in other studies involving physical activity, mindfulness, or cognitive training
Trial design
Primary purpose
Allocation
Interventional model
Masking
114 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Chih-Hsiang "Jason" Yang, PhD; Laura Phillips, B.S.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal